Suppr超能文献

地塞米松抑制大鼠肝癌细胞中纤溶酶原激活物的机制。

Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.

作者信息

Seifert S C, Gelehrter T D

出版信息

Proc Natl Acad Sci U S A. 1978 Dec;75(12):6130-3. doi: 10.1073/pnas.75.12.6130.

Abstract

Glucocorticoids rapidly and completely inhibit intracellular plasminogen activator activity in rat hepatoma cells, as assayed by the solubilization of 125I-labeled fibrin. Experiments in which extracts of dexamethasone-treated cells are mixed with extracts of control cells demonstrate an inhibitor of protease activity. Plasminogen activator is found primarily in the particulate fraction of cell lysates, whereas the inhibitor is localized in the soluble fraction. Variant cells have been isolated previously that are fully resistant to the dexamethoasone inhibition of plasminogen activator activity. These variants have no demonstrable inhibitor activity, whereas plasminogen activator in these cells is fully sensitive to inhibitor from wild-type cells. Thus, the basis for hormone resistance appears to be the failure of dexamethasone to induce an inhibitor.

摘要

通过对125I标记的纤维蛋白进行溶解测定发现,糖皮质激素能迅速且完全抑制大鼠肝癌细胞内纤溶酶原激活剂的活性。将地塞米松处理过的细胞提取物与对照细胞提取物混合进行实验,结果显示存在一种蛋白酶活性抑制剂。纤溶酶原激活剂主要存在于细胞裂解物的颗粒部分,而抑制剂则定位于可溶性部分。先前已分离出对糖皮质激素抑制纤溶酶原激活剂活性完全耐药的变异细胞。这些变异细胞没有可检测到的抑制剂活性,而这些细胞中的纤溶酶原激活剂对野生型细胞的抑制剂完全敏感。因此,激素耐药的基础似乎是地塞米松未能诱导出抑制剂。

相似文献

引用本文的文献

5
Structure and expression of the C3 gene.补体C3基因的结构与表达
Springer Semin Immunopathol. 1983;6(2-3):119-47. doi: 10.1007/BF00205869.
10
Protease-activated "prodrugs" for cancer chemotherapy.用于癌症化疗的蛋白酶激活“前药”。
Proc Natl Acad Sci U S A. 1980 Apr;77(4):2224-8. doi: 10.1073/pnas.77.4.2224.

本文引用的文献

5
Mechanism of action of glucocorticoids.糖皮质激素的作用机制。
Metabolism. 1974 Feb;23(2):159-202. doi: 10.1016/0026-0495(74)90113-9.
9
Hormonal regulation of membrane phenotype.膜表型的激素调节
J Supramol Struct. 1977;6(3):325-31. doi: 10.1002/jss.400060305.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验